(Q43264871)
Statements
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer (English)
J Chang
S-C Chen
K Cwiertka
G Jerusalem
Z Jiang
S Johnston
B Kaufman
J Link
J Ro
J Schütte
C Oliva
R Parikh
A Preston
J Rosenlund
M Selzer
D Zembryki